Processus Wealth & Capital Management’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Processus Wealth & Capital Management's AMGN Position: Q3 2026 in Review
Processus Wealth & Capital Management reduced its Amgen (AMGN) stake by 1.9% in Q3 2026, selling an estimated $82.1K and leaving 10,770 shares worth $4.54M. The position accounts for 2.64% of the portfolio, ranked #14.
Processus Wealth & Capital Management first reported a position in AMGN in Q4 2023 and has held it in 12 quarters since. 1,149 funds tracked by Wall St. Rank hold AMGN as of Q3 2026.
- Processus Wealth & Capital Management held 10,770 shares of Amgen worth $4.54M as of Q3 2026.
- Processus Wealth & Capital Management sold 206 Amgen shares in Q3 2026, an estimated $82.1K.
- Amgen made up 2.64% of Processus Wealth & Capital Management's portfolio in Q3 2026, its #14 holding.
- Processus Wealth & Capital Management first reported a position in Amgen in Q4 2023 and has held it in 12 quarters since.
- 1,149 funds tracked by Wall St. Rank held Amgen as of Q3 2026.
Based on Processus Wealth & Capital Management's 13F filing for Q3 2026, filed 16 Oct 2026.